Antibody Testing of Human Plasma Samples Using VirScan Technology

This Voluntary ex ante transparency (VEAT) notice acknowledges that Trinity College Dublin proposes to issue a contract to CDI Laboratories. This will activate laboratory based analysis services using the proprietary VirScan™ technology. The VirScan™ technology offers unique sample throughput capability and is critical to the objectives of the research programme funded by SFI at Trinity College Dublin.
CPV-Code: 85111810
Abgabefrist:
Typ: Contract award notice
Status: Not applicable
Aufgabe: Education
Vergabestelle:
name: Trinity College Dublin, the University of Dublin
address: College Green, Co. Dublin
postal_code:
city: Dublin 2 - IE
country: IE
email: None
phone: +353 18962376
contact_point: Kevin Ryan
idate: 1. Januar 2021 06:55
udate: 1. Januar 2021 06:55
doc: 602488_2020.xml
authority_types:
activities:
Quelle: http://ted.europa.eu/udl?uri=TED:NOTICE:602488-2020:TEXT:EN:HTML
Unterlagen: None
Zuschlagskriterium: Lowest price
Vertrag: Services
Prozedur: Negotiated without a prior call for competition
Nuts: None
Veröffentlichung: 14.12.2020
Erfüllungsort: Dublin -
Link:
Lose:
Name Los Nr 1 None
Gewinner CDI Laboratories
Datum
Wert 230 000,00 €
Anzahl Angebote 1